United-Guardian, Inc.
NASDAQ Global MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- United-Guardian, Inc. (Nasdaq: UG) develops, manufactures, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients. The company offers a comprehensive portfolio of hydrogels under the LUBRAJEL brand, including LUBRAJEL MG, LUBRAJEL MGL, LUBRAJEL RRCG, LUBRAJEL RR, LUBRAJEL RC, LUBRAJEL RA, LUBRAJEL Fluid, LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FACO for personal care formulations, catheter and medical device lubrication, condom applications, and oral care; NATRAJEL hydrogels tailored for the sexual wellbeing market; cosmetic ingredients such as B-122 powdered lubricant for pressed powders, eyeliners, rouges, and industrial uses, and ORCHID COMPLEX oil-based orchid extract; pharmaceuticals including RENACIDIN Irrigation Solution for preventing and dissolving urethral catheter calcifications and CLORPACTIN WCS-90 topical antimicrobial; and additional products like Klensoft, Deselex, and LUBRASIL II SB silicone-infused hydrogel. Founded in 1942 and headquartered in Hauppauge, New York, United-Guardian operates primarily from a single U.S. facility handling research, development, manufacturing, and quality control, with products sold domestically through drug wholesalers and distributors such as Ashland Specialty Ingredients, and internationally across North America, Central and South America, Europe, China, and Korea. In recent developments, the company reported mixed financial results for 2025, including Q3 net sales of $2.3 million and net income of $268,441 amid declines in certain segments, while pursuing growth initiatives such as expanded personal care market penetration, a major project to boost RENACIDIN sales following production resumption, and its 30th consecutive annual dividend payment of $0.25 per share in August 2025; it also strengthened distribution through ongoing partnerships like Ashland and maintains ISO 9001:2015 certification.
United-Guardian Declares Cash Dividend
UG Outperforms Industry in 6 Months: Buy, Sell or Hold the Stock?
Engages Danayi Capital Corp. To Provide Digital Marketing Services
Upside Gold Corp. Announces Closing of $5 Million Brokered Private Placement
Upside Gold Announces Fully Permitted Drill Program at the Kena Gold-Copper Project
United-Guardian Q1 Earnings Rise Y/Y on Strong Renacidin Demand
United-Guardian, Inc. (UG) Shareholder/Analyst Call Transcript
Upside Gold Corp. Finalizes Acquisition of Strategic High-Grade Gold Claims Adjacent to the Kena Project
United-Guardian Reports First Quarter Results
Upside Gold Corp. Signs LOI For Strategic Claims Adjacent To The Kena Property
Upside Gold Corp. Signs LOI For Strategic Claims Adjacent To The Kena Property
Upside Gold Corp. Announces Grant Of Stock Options
United-Guardian 2025 Earnings Fall Y/Y Amid Weak Sales Trends
United-Guardian Reports 2025 Financial Results
United-Guardian (NASDAQ:UG) vs. Perrigo (NYSE:PRGO) Head to Head Analysis
Reviewing Generation Alpha (OTCMKTS:GNAL) & United-Guardian (NASDAQ:UG)
UG Q3 Profit Falls Y/Y on Weak Cosmetics Sales, Stock Declines 10%
United-Guardian Reports Third Quarter Earnings
UG Q2 Earnings Fall Y/Y on Weak Cosmetic Sales, Pharma Gains
United-Guardian (UG) Q2 Sales Drop 16%